Helixgate https://validator.w3.org/feed/docs/rss2.html STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more STAT+: HHS moves to allow compounding of some unapproved peptides Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout AbbVie bids to join the BCMA crowd with etentamig GSK shares come under pressure from weaker vaccine sales Artiva to quit autoimmune cell therapy work, cut staff after patient deaths Ferring to acquire next-gen IVF startup Gameto for up to $1.4B FDA unveils guidance for ‘plug and play’ gene therapies Oruka raises efficacy expectations for long-acting IL-23 inhibitors PACE panels tackle challenges to access and barriers to coverage Behind the scenes of 3 Big Pharma layoffs Biotechs going to market alone must learn to go global Big Pharma is ready to strike, with J&J most likely to buy: Leerink Data leak kickstarts ESMO, BMS reports autoimmune CAR T death, pharma M&A outpaces 2025 Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset Lilly’s retatrutide trounces Novo’s Ozempic in diabetes, weight loss New FDA draft guidance doubles down on expediting approvals of personalized gene therapies Biogen set up for growth even without M&A but CEO won’t rule it out Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout An engineered, compact Cas12m variant for multiplexed gene activation in vivo An mRNA–lipid nanoparticle vaccine against H5N1 influenza virus protects lactating dairy cows from infection Novartis Remibrutinib Delivered Comprehensive Disease Control in Phase III RMS Trials, with Proven, Robust Safety Profile Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study Sonesitatug Vedotin Reduced the Risk of Death by 42% in 2nd- and Later-Line CLDN18.2-Positive Advanced Gastric/GEJ Cancers in CLARITY-Gastric01 Pfizer’s 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026 Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus GSK restructure will hit home, impacting ‘limited’ UK roles 13 of the best biotech incubators hatching startups in Europe The stranded asset problem in microbial custom manufacturing Best Chinese Medicines LLC – 738556 – 10/23/2026 2026 IPO stock tracker: How newly public biotechs are performing Rice plants can fight off devastating disease after gene editing with AI-designed tool Single-Cell Multiomics: Phenotypic Plasticity in Colorectal Cancer Metastasis ASHG: Nabsys Links Cytogenetics and Genomics to Map Hematologic Cancers Vitamin Derivative Pantethine Alleviates Psoriasis Symptoms in Small Human Trial Bonjour Genomics: A Video from ASHG Artiva Axes 94% of Workforce, Weighs Strategic Alternatives After Two Patients in Phase IIa Trial Die What 3 multibillion dollar biotechs still have to prove Immune-boosted boron neutron capture therapy shows striking tumor targeting in early study Blood lipid–linked DNA methylation patterns replicate in Korean adults and tie to epigenetic aging Brazil’s VigiMed database reveals radiopharmaceutical safety reporting patterns STAT+: Roche gets a lung cancer win with its KRAS drug divarasib STAT+: Moderna CEO on what’s next after success in cancer vaccine Opinion: Cancer vaccines are finally here. How do we get them to patients? STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down Woodcock: New paradigm needed to unlock therapies for rare diseases Security concerns in U.S., China reshaping biotech STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies STAT+: GSK sees its return to cancer start to pay off Home